1. Repository of OAI
Ελληνικά   English  

Browsing by Author Liberopoulos, E. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 86 to 105 of 117 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
A patient with new-onset hypercholesterolemiaLiberopoulos, E. N.; Florentin, M.; Siamopoulos, K. C.; Elisaf, M. S.24-Nov-2015-
Persistence of an atherogenic lipid profile after treatment of acute infection with brucellaApostolou, F.; Gazi, I. F.; Kostoula, A.; Tellis, C. C.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015-
Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinomaTzovaras, V.; Liberopoulos, E. N.; Zioga, A.; Pavlidis, N.; Elisaf, M. S.24-Nov-2015-
Pharmacological treatment of non-alcoholic steatohepatitis: the current evidenceDiakou, M. C.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tsianos, E. V.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevationFlorentin, M.; Liberopoulos, E. N.; Kei, A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of thiazolidinedionesRizos, C. V.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Possible cefotaxime-induced Stevens-Johnson syndromeLiberopoulos, E. N.; Liamis, G. L.; Elisaf, M. S.24-Nov-2015-
Possible ranitidine-induced cholestatic jaundiceLiberopoulos, E. N.; Nonni, A. B.; Tsianos, E. V.; Elisaf, M. S.24-Nov-2015-
Prevalence of vascular disease in metabolic syndrome using three proposed definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Liberopoulos, E. N.; Goudevenos, I. A.; Karagiannis, A.24-Nov-2015-
Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measuresLiberopoulos, E. N.; Tsouli, S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
A review of the lipid-related effects of fluvastatinLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.; Wierzbicki, A. S.; Elisaf, M. S.24-Nov-2015-
A review of the metabolic effects of sibutramineFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Review: Antiplatelet drugs: what comes next?Kei, A. A.; Florentin, M.; Mikhailidis, D. P.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
The role of C-reactive protein in atherosclerotic cardiovascular disease: an overviewNakou, E. S.; Liberopoulos, E. N.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S.24-Nov-2015-
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Should a statin be prescribed to every patient with heart failure?Tsouli, S. G.; Liberopoulos, E. N.; Goudevenos, J. A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
SIADH and hyponatremia with theophyllineLiberopoulos, E. N.; Alexandridis, G.; Christidis, D. S.; Elisaf, M. S.24-Nov-2015-
Sibutramine-associated adverse effects: a practical guide for its safe useFlorentin, M.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetesFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Showing results 86 to 105 of 117 < previous   next >